Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 37 | ECE2015 | Next issue

17th European Congress of Endocrinology

Oral Communications

Endocrine tumours

ea0037oc8.1 | Endocrine tumours | ECE2015

A role for vault particles as a marker for therapeutic effects against endocrine tumours

Hantel Constanze , Beuschlein Felix

The vault complex, consisting of a major vault protein (MVP), two minor vault proteins (VPARP and TEP1) and small untranslated RNA molecules (vault RNAs 1–4), is considered the largest intracellular ribonucleoprotein particle. Although in recent years, vaults were believed to be involved in multidrug resistance, the exact function of this complex has remained unclear. Recently, we investigated the therapeutic applicability of a Tumour-Vascular-Disrupting Agent (ASA) in pr...

ea0037oc8.2 | Endocrine tumours | ECE2015

Role of microenvironment on neuroblastoma SK-N-AS SDHB silenced cell metabolism and function

Rapizzi Elena , Fucci Rossella , Giannoni Elisa , Canu Letizia , Richter Susan , Cirri Paolo , Mannelli Massimo

Solid tumours are very complex tissues comprising not only cancer cells, but also non-malignant stromal cells such as endothelial cells, fibroblasts, immune cells and extracellular matrix, forming the so called tumour microenvironment. In the last few years, it has become more and more evident the pivotal role of the tumour microenvironment in modulating cancer progression and metastasis. Tumour microenvironment has thus become a potential therapeutic target. To obtain an expe...

ea0037oc8.3 | Endocrine tumours | ECE2015

miR-372 is aberrantly expressed in most parathyroid tumours and might contribute to parathyroid tumourigenesis by inhibiting CDKN1A/p21 and LATS2

Verdelli Chiara , Forno Irene , Vaira Valentina , Guarnieri Vito , Scillitani Alfredo , Cetani Filomena , Vicentini Leonardo , Balza Gianni , Beretta Edoardo , Corbetta Sabrina

We previously described aberrant expression of microRNAs belonging to the chromosome 19 cluster (C19MC) and the close miR-371-373 cluster in two-thirds of parathyroid carcinomas (PCas). Therefore, we investigated the involvement of the miR-371-373 cluster in parathyroid tumours, where miR-372 was the most consistently upregulated. miR-372 is known to be highly expressed in human embryonic stem cells and definitely downregulated upon differentiation. Moreover, miR-372 promotes ...

ea0037oc8.4 | Endocrine tumours | ECE2015

The effects of peptides with oestrogen-like activity on cell proliferation and on energy metabolism in human derived tumour cell lines

Somjen Dalia , Katzburg Sara , Gayer Batya , Kasher Roni , Kohen Forune , Sharon Orli , Stern Naftali

Oestradiol-17β regulates diverse tissues and cells, both within and outside the reproductive system including human cancer cells. Currently used ERs agonists or antagonists are synthetic compounds prepared by structure modifications. Alternatively, peptide mimics of steroids would allow preparation of biased combinatorial libraries of chemical and biological origin, from which estrogenic peptides with tissue selective profiles can be selected. The phage-display peptide li...

ea0037oc8.5 | Endocrine tumours | ECE2015

Oestrogen receptor α promotes prostate cancer progression through dual actions in both epithelia and stroma

Lawrence Mitchell , Pidsley Ruth , Ellem Stuart , Furic Luc , Nair Shalima , French Hugh , Stratham Aaron , Larsson Ola , Frydenberg Mark , Pedersen John , Buchanan Grant , Taylor Renea , Clark Susan , Risbridger Gail

In human prostate, Oestrogen receptor α (ERα) expression in the epithelium increases with tumour Grade and promotes proliferation involving classical genomic and rapid non-genomic signalling, as well as transcription regulation of non-coding RNA. Similarly, in the tumour stroma there is up-regulation of ERα, corresponding with declining AR, resulting in a higher ratio of ERα:AR with increasing Grade. Additionally, in prostate cancer-associated fibroblasts (...